PEFR (GIV) Duration 10 days · acute asthma exacerbation
1 finding from 1 review
Outcomes (end of treatment) · people with dementia (all resided in institutional settings)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Emotional well‐being including quality of life · people with dementia (all resided in institutional settings)
2 findings from 1 review
Mood disturbance or negative affect: depression · people with dementia (all resided in institutional settings)
2 findings from 1 review
Mood disturbance or negative affect: anxiety · people with dementia (all resided in institutional settings)
2 findings from 1 review
Behavioural problems: agitation or aggression · people with dementia (all resided in institutional settings)
2 findings from 1 review
Behavioural problems: overall · people with dementia (all resided in institutional settings)
2 findings from 1 review
Social behaviour: music vs other activities · people with dementia (all resided in institutional settings)
2 findings from 1 review
Cognitive function · people with dementia (all resided in institutional settings)
2 findings from 1 review
Outcomes (long‐term) · people with dementia (all resided in institutional settings)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Control of epistaxis: episodes of re‐bleeding over 10 days All treatments (topical and oral) · adults with nasal haemorrhage (epistaxis)
Tranexamic acid probably leads to lower control of epistaxis: episodes of re‐bleeding over 10 days All… compared with placebo plus usual care or usual care alone (moderate certainty).
1 finding from 1 review
Control of epistaxis: episodes of re‐bleeding over 10 days Oral treatment only · adults with nasal haemorrhage (epistaxis)
Tranexamic acid probably leads to lower control of epistaxis: episodes of re‐bleeding over 10 days Oral… compared with placebo plus usual care or usual care alone (moderate certainty).
1 finding from 1 review
Control of epistaxis: episodes of re‐bleeding over 10 days Topical application (10% gel) only · adults with nasal haemorrhage (epistaxis)
Tranexamic acid showed no clear difference in control of epistaxis: episodes of re‐bleeding over 10 days Topical… compared with placebo plus usual care or usual care alone (low certainty).
1 finding from 1 review
Control of epistaxis: time to stop initial bleeding (proportion of patients whose bleeding is controlled in ≤ 30 minutes) · adults with nasal haemorrhage (epistaxis)
Tranexamic acid showed no clear difference in control of epistaxis: time to stop initial bleeding (proportion of… compared with placebo plus usual care or usual care alone (low certainty).
1 finding from 1 review
Severity of re‐bleeding: proportion of patients requiring blood transfusion within 10 days · adults with nasal haemorrhage (epistaxis)
Tranexamic acid showed no clear difference in severity of re‐bleeding: proportion of patients requiring blood… compared with placebo plus usual care or usual care alone (low certainty).
1 finding from 1 review
Length of hospital stay · adults with nasal haemorrhage (epistaxis)
Tranexamic acid showed no clear difference in length of hospital stay compared with placebo plus usual care or usual care alone; GRADE not reported.
1 finding from 1 review
Adverse effects: serious or other · adults with nasal haemorrhage (epistaxis)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (all causes) · people with CKD
It is very uncertain whether summary of findings: Sevelamer changes death (all causes) compared with placebo/usual care (very low certainty).
1 finding from 1 review
Cardiovascular mortality · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nausea · people with CKD
Summary of findings: Lanthanum may leads to higher nausea compared with placebo/usual care (low certainty).
1 finding from 1 review